Resistance of leukemia cells to cytarabine chemotherapy is mediated by bone marrow stroma, involves cell-surface equilibrative nucleoside transporter-1 removal and correlates with patient outcome.
about
Induction treatment of acute myeloid leukemia in an elderly patient with intramarrow injection/administration of cytarabine. Second case report.Distinct signaling events promote resistance to mitoxantrone and etoposide in pediatric AML: a Children's Oncology Group report.Histone deacetylase inhibitors reduce differentiating osteoblast-mediated protection of acute myeloid leukemia cells from cytarabine.
P2860
Resistance of leukemia cells to cytarabine chemotherapy is mediated by bone marrow stroma, involves cell-surface equilibrative nucleoside transporter-1 removal and correlates with patient outcome.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Resistance of leukemia cells t ...... rrelates with patient outcome.
@en
type
label
Resistance of leukemia cells t ...... rrelates with patient outcome.
@en
prefLabel
Resistance of leukemia cells t ...... rrelates with patient outcome.
@en
P2093
P2860
P356
P1433
P1476
Resistance of leukemia cells t ...... rrelates with patient outcome.
@en
P2093
Alfonso González
Bruno Nervi
Claudia Oyanadel
Daniel Ernst
Felipe Court
Mauricio Ocqueteau
Pablo Ramirez
Patricia García
Patricia Macanas-Pirard
Richard Broekhuizen
P2860
P304
23073-23086
P356
10.18632/ONCOTARGET.14981
P407
P577
2017-02-01T00:00:00Z